Bromfenac Impurity 13 | CAS 2190492-17-0 - Request Quote
Bromfenac Impurity 13
| SZ CAT No: | SZ-B033028 |
| CAS No | 2190492-17-0 |
| Mol.F. | C30H16Br4N2O2 |
| Mol.Wt. | 756.1 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Bromfenac Impurity 13 is chemically (3,3'-Dibromo-1H,1'H-[5,5'-biindole]-7,7'-diyl)bis((4-bromophenyl)methanone). Bromfenac Impurity 13 is supplied with detailed characterization data compliant with regulatory guideline. Bromfenac Impurity 13 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Bromfenac.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2190492-17-0
Purchase 2190492-17-0
Order 2190492-17-0
Enquire 2190492-17-0
price of 2190492-17-0
2190492-17-0 Supplier
2190492-17-0 Manufacturer
2190492-17-0 Exporter
buy high quality Bromfenac Impurity 13
Purchase Bromfenac Impurity 13
Bromfenac Impurity 13 suppliers
Bromfenac Impurity 13 manufacturers
Bromfenac Impurity 13 price
Order Bromfenac Impurity 13
Enquire Bromfenac Impurity 13
Bromfenac Impurity 13 cost
Bromfenac Impurity 13 Supplier
Bromfenac Impurity 13 Distributor
Bromfenac Impurity 13 for Method Validation
Bromfenac Reference Standard
Bromfenac Impurity 13 for ANDA Filing
Bromfenac Impurity 13 for Forced Degradation Studies
Bromfenac Impurity 13 Identification Standards
Bromfenac Impurity 13 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


